Article
A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy.
Neuromuscular disorders : NMD - 1 Mar 2013
Kierdaszuk Biruta, Berdynski Mariusz, Karolczak Justyna, Redowicz Maria Jolanta, Zekanowski Cezary, Kaminska Anna M
Abstract excerpt
Centronuclear myopathies constitute a group of heterogeneous congenital myopathies characterized by the presence of abnormal, centrally located nuclei within muscle fibers. Centronuclear myopathies can be caused by mutations of several different genes, including DNM2, encoding dynamin 2 (DNM2) a large GTPase involved in membrane trafficking and endocytosis. We report a 52-year-old female with slowly progressive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
